7 research outputs found

    Active packaging films based on polyolefins modified by organic and inorganic nanoparticles

    No full text
    Nowadays, the use of polymer films for flexible packaging has gained a widespread importance because of their easy processing, good final properties, light weight and low relative cost. In order to fulfill the needs of increasingly demanding consumers respect to the quality of packaged products, additional capabilities must be incorporated into packaging. In this sense, academic and industrial efforts have focused on new technologies that provide a complementary functionality to the packaging performance. These emerging developments involve active and intelligent packaging, which can attract to consumers, improve product quality and/or balance any detrimental effect. In this context, the use of nanoparticle (NP) modified polyolefins, either in bulk (nanocomposites) or on the surface, allows the inclusion of specific functionalities. These new capabilities enable obtaining active packaging according to the requirements of the product. The aim of this chapter is to analyze the aforementioned approaches for the development of active films by incorporating antibacterial, antifungal and/or repellent functionalities. Currently, several sustainable developments of this type of active films are based on commodity thermoplastics such as poly(ethylene) and poly(propylene). These materials, modified by the incorporation of organic and inorganic NPs, are promising candidates since their final properties can be tailored for packaging application.Fil: Alonso, Yanela Natalin. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Planta Piloto de Ingeniería Química. Universidad Nacional del Sur. Planta Piloto de Ingeniería Química; Argentina. Universidad Nacional del Sur. Departamento de Ingeniería Química; ArgentinaFil: Grafia, Ana Luisa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Planta Piloto de Ingeniería Química. Universidad Nacional del Sur. Planta Piloto de Ingeniería Química; Argentina. Universidad Nacional del Sur. Departamento de Ingeniería Química; ArgentinaFil: Castillo, Luciana Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Planta Piloto de Ingeniería Química. Universidad Nacional del Sur. Planta Piloto de Ingeniería Química; Argentina. Universidad Nacional del Sur. Departamento de Ingeniería Química; ArgentinaFil: Barbosa, Silvia Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Planta Piloto de Ingeniería Química. Universidad Nacional del Sur. Planta Piloto de Ingeniería Química; Argentina. Universidad Nacional del Sur. Departamento de Ingeniería Química; Argentin

    A second update on mapping the human genetic architecture of COVID-19

    Get PDF

    Mapping the human genetic architecture of COVID-19

    Get PDF
    The genetic make-up of an individual contributes to the susceptibility and response to viral infection. Although environmental, clinical and social factors have a role in the chance of exposure to SARS-CoV-2 and the severity of COVID-191,2, host genetics may also be important. Identifying host-specific genetic factors may reveal biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We formed a global network of researchers to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity. Here we describe the results of three genome-wide association meta-analyses that consist of up to 49,562 patients with COVID-19 from 46 studies across 19 countries. We report 13 genome-wide significant loci that are associated with SARS-CoV-2 infection or severe manifestations of COVID-19. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases3,4,5,6,7. They also represent potentially actionable mechanisms in response to infection. Mendelian randomization analyses support a causal role for smoking and body-mass index for severe COVID-19 although not for type II diabetes. The identification of novel host genetic factors associated with COVID-19 was made possible by the community of human genetics researchers coming together to prioritize the sharing of data, results, resources and analytical frameworks. This working model of international collaboration underscores what is possible for future genetic discoveries in emerging pandemics, or indeed for any complex human disease
    corecore